The Yield Lab Europe Fund 1 Limited Partnership investment portfolio

Glaia develops carbon‑based nanotechnology biostimulants that enhance photosynthesis and increase crop yields without additional fertilizer, targeting growers and the sustainable‑agriculture market. It is commercialising its technology in the UK, initially with the product Fragaria Plus.

NoBACZ Healthcare develops antibiotic‑free, patented wound‑care formulations that create instant, waterproof barriers, targeting livestock wound management as well as veterinary and human bandaging markets. The products are engineered to be tough for farm use while remaining biodegradable.